Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Patent Profile: Ulysses Pharmaceuticals Announces Issuance of Patent for Novel Class of Antibiotics

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Donald Zuhn -- Ulysses Pharmaceuticals announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,410,974, which is directed to a class of compounds that exhibit antibiotic activity against a wide spectrum of microorganisms, including organisms that are resistant to multiple antibiotic families (the so-called "superbugs"). According to Ulysses Pharmaceuticals' statement, the nitrofuran antibiotics of the '974 patent are "designed to make the development of [drug] resistance almost impossible, because of their exquisite potency, rapid killing of bacteria and multiple mechanisms of action." The Sherbrooke, Quebec-based biotech company, which focuses on the discovery and development...

Full post as published by Patent Docs on August 13, 2008 (boomark / email).